Research Awards Listing
Research follows dollars, and The Lustgarten Foundation believes that increasing funds for pancreatic cancer research will translate into enhanced patient care, and ultimately, a cure.
The Foundation provides the best and brightest minds with the resources and flexibility to pursue science of the highest quality. To date, we have committed more than $22 million for the study of pancreatic cancer research. What began as a small but dedicated community of pancreatic cancer researchers is now a critical mass of investigators with shared interest in the disease.
By Year
2010
University of Texas M.D. Anderson Cancer Center
Rosa F. Hwang, M.D.
Wnt signaling in pancreatic cancer associated stroma
Columbia University
Thomas Ludwig, Ph.D.
The role of PALB2/FANCN in the development of pancreatic cancers
Johns Hopkins University
Akhilesh Pandey, M.D., Ph.D.
Kinome profiling to identify novel therapeutic targets in pancreatic cancer
Rockefeller University
Ralph Steinman, M.D.
Immunotherapy of pancreatic cancer by targeting mesothelin to activated dendritic cells in vivo
2009
Johns Hopkins University
Nita Ahuja, M.D.
Aberrant Hypermethylation of CpG Island Promoters in Pancreatic Cancer: Constructing a Hypermethylome
University of California, San Francisco
Allan Balmain, Ph.D.
Therapeutic Approaches to Pancreatic Cancer Based on K-Ras Isoform 4A Expression in Stem Cells
Fred Hutchinson Cancer Research Center
Sunil R. Hingorani, M.D., Ph.D.
Oncogenic K-Ras as a Therapeutic Target for Pancreas Cancer
Johns Hopkins University
Allison Klein, Ph.D.
Identification of Pancreatic Cancer Susceptibility Genes
University of Michigan Medical School
Chandan Kumar, Ph.D.
Discovery of Recurrent Gene Fusions in Pancreatic Cancer using High-Throughput Sequencing
Johns Hopkins University School of Medicine
Joshua Mendell, M.D., Ph.D.
Ras-regulated microRNAs in Pancreatic Cancer
Massachusetts General Hospital
Jeffrey Settleman, Ph.D.
Identification and Validation of Novel Therapeutics Targets for K-Ras-mutant Pancreatic Cancer
Ohio State University
Thomas D. Schmittgen, Ph.D.
MicroRNA Profiling in Serum of Pancreatic Adenocarcinoma Patients
*Supported by a generous donation from the Michael Rolfe Pancreatic Cancer Foundation
The Johns Hopkins University School of Medicine
Bert Vogelstein, M.D.
Development of Novel Diagnostic Approaches for the Early Detection of Pancreatic Neoplasms
Top of Page
2008
Columbia University
Timothy Wang, M.D.
Development of An Inflammation-Based Pancreatic Cancer Model and Exploration of the Origins of Pancreatic Cancer
Supported by a generous donation from The Lefkofsky Family Foundation
Dana-Farber Cancer Institute
James DeCaprio, M.D.
The Pancreatic Cancer Biomarker Initiative
Dartmouth College
Catherine Carrière, Ph.D.
Adult Pancreatic Progenitor Cells as Targets of Oncogenic Events
Johns Hopkins Medical Institutions
Michael Goggins, M.D.
Novel Strategies and Technologies for Identifying Familial Pancreatic Cancer Genes
Johns Hopkins Medical Institutions
Anirban Maitra, MBBS
Targeting the Herpes Virus Entry Mediator (HVEM) As A Novel Therapeutic Strategy in Pancreatic Cancer
Massachusetts General Hospital
Kimberly A. Kelly, Ph.D.
Plectin-1 As A Biomarker for the Early Detection of Pancreatic Ductal Adenocarcinoma
Mayo Clinic College of Medicine
Fergus J. Couch, Ph.D.
Genetic Epidemiology of Novel Pancreatic Cancer Susceptibility Genes
The Canary Foundation
Brad Nelson, Ph.D.
The Pancreatic Cancer Biomarker Initiative
University of California at San Francisco
James D. Marks, M.D., Ph.D.
The Pancreatic Cancer Biomarker Initiative
Van Andel Research Institute
Brian B. Cao, M.D.
The Pancreatic Cancer Biomarker Initiative
Top of Page
2007
Dana-Farber Cancer Institute
David Frank, M.D., Ph.D.
Inhibition of STAT3 in the Targeted Therapy of Pancreatic Cancer
Johns Hopkins Medical Institutions
James Eshleman, M.D., Ph.D.
Pancreatic Cancer Tumor Suppressor Gene Discovery using RNAi
Johns Hopkins Medical Institutions
Anirban Maitra, MBBS
Synergistic Targeting of the Apoptotic Machinery in Pancreatic Cancer
Johns Hopkins Medical Institutions
Bert Vogelstein, M.D.
Sequencing the Pancreatic Cancer Genome
Purdue University
Stephen F. Konieczny, Ph.D.
Mist 1 Kras G12D Generated Pancreatic Cancer
Salk Institute for Biological Studies
Inder M. Verma, Ph.D.
A Novel Mouse Model of Pancreatic Cancer Using Lentiviral Vectors
Samuel Lunenfeld Research Institute
Steven Gallinger, M.D.
Characterization of Germline DNA Copy Number Variation in Familial Pancreas Cancer
University of California at San Francisco Comprehensive Cancer Center
Martin McMahon, Ph.D.
Targeting Kinases to Overcome Gemcitabine Resistance in Pancreatic Carcinoma
Top of Page
2006
Cambridge Research Institute
David Tuveson, M.D., Ph.D.
Novel Anti-K-ras Strategies in Ductal Pancreatic Cancer
Georgetown University Medical Center
Anna Riegel, Ph.D.
The Role of the Nuclear Receptor Coactivator AIB1in the Early Preneoplastic Stages of Pancreatic Cancer
Johns Hopkins Medical Institutions
Marcia Canto, M.D.
Screening for Early Pancreatic Neoplasia: A Multi-Center Study
Johns Hopkins Medical Institutions
Elizabeth Jaffee, M.D.
Functional Genomic Approach to Identify Genes that are Pancreatic Cancer Immune Targets
Johns Hopkins Medical Institutions
Steven D. Leach, M.D.
High-Throughput, In-Vivo Screening for Novel Pancreatic Cancer Drugs Using the Zebrafish System
Johns Hopkins Medical Institutions
Joshua Mendell, M.D., Ph.D.
The Role of MicroRNAs in the Pathogenesis of Pancreatic Cancer
Technical University of Munich
Roland Schmid, M.D.
Jens T. Svieke, M.D.
The Role of Notch Signaling in Pancreatic Cancer Development
University of Michigan Medical Center
Diane Simeone, M.D.
Pancreatic Cancer Stem Cells
University of Texas M.D. Anderson Cancer Center
George Halder, Ph.D.
A Novel Genetic System to Identify Ideal Cancer Drug Targets in Pancreatic Cancer
University of Utah
Lewis Charles Murtaugh, Ph.D.
Interdependence of Notch and Kras Signaling in Pancreatic Tumorigenesis
Top of Page
2005
Johns Hopkins Medical Institutions
Steven Leach, M.D.
Zebrafish Model of Early Pancreatic Cancer
Massachusetts General Hospital
Kimberly Kelly, Ph.D.
Development of Molecular Imaging Agents for Early Detection of Pancreatic Cancer
Massachusetts General Hospital
Sarah Thayer, M.D., Ph.D.
Shh Links Chronic Inflammatory Injury to Pancreatic Carcinogenesis
Mayo Clinic
Amy Tang, Ph.D.
SIAH: A Novel Biomarker of Pancreatic Cancer Progression and Therapeutic Implications
Technical University of Munich
Roland Schmid, M.D.
The Role of Notch Signaling in the Kras Mouse Model of Pancreatic Cancer
Top of Page
2004
Dana-Farber Cancer Institute
Nabeel Bardeesy, Ph.D.
Pancreatic Cancer Models for The Identification of Biomarkers and Tumor Maintenance Programs
Johns Hopkins Medical Institutions
Anirban Maitra, MBBS
Hedgehog Inhibitors of Pancreatic Cancer
Mayo Clinic College of Medicine
Janet Olsen, Ph.D.
Identification of Early Stage Pancreatic Cancer Biomarkers using LC-Dual ESI-FT-ICR Mass Spectrometry
Mayo Clinic at Rochester
Suresh T. Chari, M.D.
Serum Proteomics of Pancreatic Cancer- Induced Diabetes
Meharry Medical College and Vanderbilt University
Ana M. Grau, M.D.
Role of Rhob in Tumorigenesis and Metastasis In Pancreatic Cancer
Memorial Sloan-Kettering Cancer Center
Richard N. Kolesnick, M.D.
Development of KSR Phosphorothioate Antisense Oligonucleotides in the Treatment of Human Pancreatic Cancer
Mt. Sinai Hospital, Toronto / Samuel Lunenfeld Research Institute
Steven Gallinger, M.D.
A Novel Pancreatic Cancer Tumor Suppressor Candidate Gene
New York University School of Medicine
Daniel Meruelo, Ph.D.
Imaging-Assisted Design of Viral Vectors to Eradicate Metastatic Pancreatic Cancer
Northwestern University
Paul Grippo, Ph.D.
Dual Targeting of Mutant Kras And Muchin1 in Mice That Develop Human Like Panins
Stanford University School of Medicine
Jonathan Pollack, M.D., Ph.D.
Locating Novel Pancreatic Cancer Genes with DNA Microarrays
State University of New York at Stony Brook
Dafna Bar-Sagi, Ph.D.
Analysis of Pancreatic Ductal Adenocarcinoma Progression in a Mouse Model of Hereditary Pancreatitis
University of Alabama at Birmingham
Pierre L. Triozzi, M.D.
ErbB Receptor Immunotherapy
University of California at San Francisco
Matthias Hebrok, Ph.D.
Embryonic Signaling Pathways in Pancreatic Cancer
University of Michigan Medical Center
Diane M. Simeone, M.D.
Development and Validation of Novel Biomarkers for Early Pancreatic Cancer Detection
Top of Page
2003
Aston University, United Kingdom
Michael Tisdale, Dsc., Ph.D.
Cloning and Expression of a Muscle Receptor for a Cancer Cachectic Factor
Cold Spring Harbor Laboratory
Robert Lucito, Ph.D.
Genomic Analysis of Pancreatic Cancer Using DNA Microarrays
Columbia University, College of Physicians and Surgeons
Paul B. Fisher, Ph.D.
Exploiting Defects in Molecular Circuitry to Selectively Kill Pancreatic Cancer Cells
Dana-Farber Cancer Institute
Nabeel Bardeesy, Ph.D.
Preclinical Model System for Kras Directed Pancreatic Tumor Maintenance and Biomarker Identification
Dana-Farber Cancer Institute/ Harvard Medical School
Lynda Chin, M.D.
Comprehensive View of Pancreatic Cancer Oncogenomics
Dana-Farber Cancer Institute
Charles Fuchs, M.D., M.P.H.
Prospective Study of Pancreatic Cancer Pathogenesis
Dana-Farber Cancer Institute / Harvard Medical School
Muneesh Tewari, M.D., Ph.D.
A Synthetic Lethal Screen to Discover Tumor-Selective Drug Targets in Pancreatic Cancer
Johns Hopkins Medical Institutions
Michael Goggins, M.D.
Proteomic Profiles of Pancreatic Juice for the Early Detection of Pancreatic Cancer
Johns Hopkins Medical Institutions
Christine Iacobuzio-Donahue, M.D., Ph.D.
Towards a Comprehensive Understanding of Pancreas Cancer Through Gene Expression Profiling
Johns Hopkins Medical Institutions
Gloria Su, Ph.D.
Identification of Tissue-Specific Promoters for Ductal Epithelium of Pancreas Using SAGE Libraries
Massachusetts General Hospital/ Harvard Medical School
Sarah Thayer, M.D., Ph.D.
To Characterize the Contribution of Sonic Hedgehog to Pancreatic Neoplasia
Memorial Sloan-Kettering Cancer Center
Gary K. Schwartz, M.D.
Clinical Development of Flavorpiridol for Patients With Locally Advanced and Metastatic Pancreatic Cancer
Stanford University School of Medicine
Jonathan R. Pollack, M.D., Ph.D.
Locating Novel Pancreatic Cancer Genes With DNA Microarrays
University of Washington
Teresa Brentnall, M.D.
Discovery of a Familial Pancreatic Cancer Gene
Top of Page
2002
Columbia University
Argiris Efstratiadis, M.D., Ph.D.
Development of a Mouse Model of Pancreatic Cancer
Johns Hopkins Medical Institutions
Anirban Maitra, MBBS
Genetic Basis of Familial Pancreatic Cancer: A Novel Approach Using Whole Genome Conversion and High-Throughput Oligonucleotide Microarrays
Mayo Clinic at Rochester
Raul Urrutia, M.D.
Role of Novel Sp1-like Proteins in the Transcriptional Silencing Carcinogen-activating Enzymes in Exocrine Pancreatic Cells
Stanford University
Albert Koong, M.D., Ph.D.
Selective Modulators of Protein Kinase C Activity as a Novel Class of Hypoxia Cell Cytotoxins in Human Pancreatic Cancer
Stanford University
Anson W. Lowe, M.D.
Characterizing the Gene-expression Profile of Human Pancreatic Cancers
University of California at Davis Cancer Center
Richard Bold, M.D.
Anti-apoptotic Signaling through the AKT Kinase in Pancreatic Cancer
University of California at San Francisco Comprehensive Cancer Center
Martin McMahon, Ph.D.
A Systematic, Genome-Wide Analysis of Gene Copy Number Alteration in Pancreatic Cancer Cells by Array CGH
University of Michigan
Craig Logsdon, Ph.D.
The Role of ATDC in Radioresistance of Pancreatic Adenocarcinoma
University of Nebraska Medical Center/Eppley Cancer Research Institute
Michel Ouellette, Ph.D.
In-Vitro Models of Pancreatic Cancer Development
University of North Carolina at Chapel Hill
Adrienne D. Cox, Ph.D.
Functional Consequences of Oncogenically Mutated Kras in Pancreatic Cancer
University of Pittsburgh Cancer Institute
Katherine Pogue-Geile, Ph.D.
Functional Identification of Pancreatic Tumor Suppressor Genes
University of Pittsburgh Cancer Institute
Ramesh K. Ramanathan, M.D.
Co-Principal Investigator: Olivera Finn, Ph.D.
Phase I/II Study of a MUC-1 Pulsed Dendritic Cell Vaccine In Resected Pancreatic and Biliary Cancers
University of Texas M.D. Anderson Cancer Center
Lee Ellis, M.D.
Role of Neuropilin-1 in Pancreatic Cancer Growth and Angiogenesis
Top of Page
2001
Aston University, United Kingdom
Michael J. Tisdale, DSc., Ph.D.
Mechanism of Muscle Protein Catabolism in Cancer Cachexia
Beth Israel Deaconess Medical Center
Hava Avraham Ph.D.
Studies of CHK Kinase in Pancreatic Cancer Cells
Harvard School of Public Health
Eric J. Duell, Ph.D.
Gene-Environment Interactions in Pancreatic Adenocarcinoma
Johns Hopkins Medical Institutions
Michael G. Goggins, M.D.
Proteomic Profiles of Pancreatic Cancer
Johns Hopkins Medical Institutions
Gloria Su, Ph.D.
Mouse Models for Human Pancreatic Cancer
Johns Hopkins Medical Institutions
Steven D. Leach, M.D.
Notch Signaling in Pancreatic Cancer Precursors
Mayo Clinic at Rochester
Gloria M. Peterson, Ph.D.
Genetic Epidemiology of Pancreatic Cancer
Memorial Sloan-Kettering Cancer Center
Yuman Fong, M.D.
Synergy of Herpes Viruses with Chemotherapy or Immunotherapy in the Treatment of Pancreatic Cancer
SUNY Downstate Medical Center
Josef Michl, M.D.
Matthew R. Pincus, M.D., Ph.D.
Novel Methods in the Diagnosis and Treatment of Pancreatic Cancer
University of Alabama at Birmingham
David T. Curiel, M.D.
Pancreatic Carcinoma Specific Replicative Adenoviral Agent
University of Pittsburgh
David C. Whitcomb, M.D., Ph.D.
Identify Genes Which are Only Expressed in Pancreatic Cancer Cells
University of Texas M.D. Anderson Cancer Center
Shrikanth A. G. Reddy, Ph.D.
AP-1 and Ras Signaling in Pancreatic Cancer Cells
Top of Page
1998 – 2000
Duke University Medical Center
Douglas Tyler, M.D.
Immunotherapy of Pancreatic Cancer Using Dendritic Cells Pulsed with Antigen in the Form of Amplified Total Tumor R
Johns Hopkins Medical Institutions
Michael Goggins, M.D.
Detect Early Symptomless Pancreatic Cancer
Johns Hopkins Medical Institutions
Constance Griffin, M.D.
Chromosome Analysis in Patients with Familial Pancreatic Cancer
Johns Hopkins Medical Institutions
Elizabeth Jaffee, M.D.
A Phase II Study of an Allogeneic Gm-CSF Secreting Pancreatic Tumor Vaccine
University of Texas M.D. Anderson Cancer Center
Keping Xie, M.D., Ph.D.
Control of Pancreatic Cancer Metastasis by Modulating Tumor-associated Nitric Oxide Production
Creighton University School of Medicine
Thomas Adrian, Ph.D.
LOX Inhibitors for Pancreatic Cancer Treatment and Prevention
University of California at San Francisco Comprehensive Cancer Center
Margaret Tempero, M.D.
Optimizing Therapy for Pancreatic Adenocarcinoma with TALL-104 Cells
University of Texas at San Antonio
James Freeman, Ph.D.
TGF-B Type II Receptor Gene as a Target for the Antitumor Effect of Farnesyltransferace Inhibitors in Pancreatic Cancer
University of Texas M.D. Anderson Cancer Center
Robert Radinsky, Ph.D.
Blocking Tumor Growth Factor Receptors in Pancreatic Tumor Cells
Top of Page